Prices delayed by at least 15 minutes | Print
Ark Invest Ucits Icav ARK GENOMIC REVOLUTION UCITS ETF
Open
$7.997
Previous close
$7.938
Trade high
$7.999
Income frequency
-
Year low
$4.678
Year high
$10.934
Replication method
NOT Applicable
Volume
1,163
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.75
ISIN
IE000O5M6XO1
Share price
Asset allocation
Top 10 holdings
| Holdings 13/11/2026 | % of assets |
|---|---|
| Tempus AI Inc Class A common stock | 9.41 |
| Twist Bioscience Corp | 7.28 |
| 10x Genomics Inc Ordinary Shares - Class A | 6.45 |
| Eli Lilly and Co | 5.43 |
| CareDx Inc | 5.05 |
| Natera Inc | 4.97 |
| CRISPR Therapeutics AG | 4.96 |
| Illumina Inc | 4.89 |
| Absci Corp | 4.53 |
| Beam Therapeutics Inc | 3.63 |
Investment objective
The investment objective of the Fund is to generate long term capital growth (5 years or more). The Fund uses an active investment management strategy to achieve the Fund’s investment objective. The Fund will invest, under normal circumstances, primarily in global equity securities of companies across multiple sectors
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.